Literature DB >> 15627481

The L-arginine/NO pathway in the early phases of platelet stimulation by collagen.

Giuliana Leoncini1, Debora Bruzzese, Maria Grazia Signorello.   

Abstract

Nitric oxide production, L-arginine transport and intracellular [Ca2+] changes in human platelets stimulated without stirring by low doses of collagen have been evaluated. Collagen decreased in a dose-dependent manner the nitric oxide formation. A reduction of about 30% of the basal level was produced by 5 microg/mL. Aspirin did not change the collagen effect. The inhibition was reversed by EGTA. Moreover collagen reduced L-arginine uptake. The exposure of platelets to 5 microg/mL collagen diminished of about 30% L-arginine transport. The specific involvement of the system y+ is suggested. In addition in FURA 2-loaded platelets collagen induced a dose-dependent slow sustained [Ca2+] rise that was almost completely cancelled by EGTA. Finally the treatment of whole platelets with collagen affected in a dose-dependent manner the maximal nitric oxide formation, suggesting a direct effect at the level of nitric oxide synthase enzyme. The phosphorylation of specific serine/threonine residues regulated by protein kinase C could be involved. In conclusion during the early phases of platelet stimulation with collagen nitric oxide formation is diminished. This reduction can be due to a lower availability of L-arginine for cytosolic nitric oxide synthase and/or to a decreased activity related to modifications of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15627481     DOI: 10.1016/j.bcp.2004.09.022

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  3 in total

1.  The mediation of platelet quiescence by NO-releasing polymers via cGMP-induced serine 239 phosphorylation of vasodilator-stimulated phosphoprotein.

Authors:  Terry C Major; Hitesh Handa; Elizabeth J Brisbois; Melissa M Reynolds; Gail M Annich; Mark E Meyerhoff; Robert H Bartlett
Journal:  Biomaterials       Date:  2013-07-29       Impact factor: 12.479

2.  The effect of lipopolysaccharide from Proteus mirabilis on the level of the stable end metabolic products of nitric oxide in blood platelets.

Authors:  J Saluk-Juszczak; B Olas; P Nowak; J Kolodziejczyk; B Wachowicz; A Zgirski
Journal:  Curr Microbiol       Date:  2006-12-06       Impact factor: 2.188

Review 3.  Development and hemocompatibility testing of nitric oxide releasing polymers using a rabbit model of thrombogenicity.

Authors:  Terry C Major; Hitesh Handa; Gail M Annich; Robert H Bartlett
Journal:  J Biomater Appl       Date:  2014-06-16       Impact factor: 2.646

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.